CAPRICOR THERAPEUTICS, INC. Impairment of Intangible Assets (Excluding Goodwill)
CAPRICOR THERAPEUTICS, INC. (CAPR) reported Impairment of Intangible Assets (Excluding Goodwill) of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-22.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill · last filed 2018-03-22
- CAPRICOR THERAPEUTICS, INC. impairment of intangible assets (excluding goodwill) for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- CAPRICOR THERAPEUTICS, INC. impairment of intangible assets (excluding goodwill) for the quarter ending 2016-12-31 was $1.50M.
- CAPRICOR THERAPEUTICS, INC. impairment of intangible assets (excluding goodwill) for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- CAPRICOR THERAPEUTICS, INC. impairment of intangible assets (excluding goodwill) for fiscal 2016 was $1.50M.
- CAPRICOR THERAPEUTICS, INC. impairment of intangible assets (excluding goodwill) for fiscal 2015 was $0.00.
| Period end | Impairment of Intangible Assets (Excluding Goodwill) 3 month | Impairment of Intangible Assets (Excluding Goodwill) 9 month | Impairment of Intangible Assets (Excluding Goodwill) 12 month |
|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | $0.00 10-K · filed 2018-03-22 | |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-14 | ||
| 2016-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | $1.50M 10-K · filed 2018-03-22 | |
| 2016-09-30 | $0.00 10-Q · filed 2017-11-14 | ||
| 2015-12-31 | $0.00 10-K · filed 2017-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |